Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity
Adrian Y. S. Lee
Rheumatology International (2017) Vol. 37, Iss. 8, pp. 1323-1333
Closed Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases
A. Robbins, Maxime Hentzien, S. Toquet, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 85
<p>Sj&ouml;gren&#39;s syndrome and systemic lupus erythematosus: links and risks</p>
Sandra Gofinet Pasoto, Victor Adriano de Oliveira Martins, Eloísa Bonfá
Open Access Rheumatology Research and Reviews (2019) Vol. Volume 11, pp. 33-45
Open Access | Times Cited: 81
African Swine Fever Virus MGF360-14L Negatively Regulates Type I Interferon Signaling by Targeting IRF3
Yang Wang, Shuai Cui, Ting Xin, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 50
Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis
Sepehr Nayebirad, Aida Mohamadi, Hannaneh Yousefi‐Koma, et al.
BMJ Open Respiratory Research (2023) Vol. 10, Iss. 1, pp. e002076-e002076
Open Access | Times Cited: 27
E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis
Luting Yang, Liang Jin, Yao Ke, et al.
Journal of Investigative Dermatology (2018) Vol. 138, Iss. 12, pp. 2568-2577
Open Access | Times Cited: 77
TRIM21 suppresses CHK1 activation by preferentially targeting CLASPIN for K63-linked ubiquitination
Xuefei Zhu, Jingwei Xue, Xing Jiang, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 3, pp. 1517-1530
Open Access | Times Cited: 34
TRIM proteins
Milica Vunjak, Gijs A. Versteeg
Current Biology (2019) Vol. 29, Iss. 2, pp. R42-R44
Open Access | Times Cited: 52
Characteristics of patients with primary Sjögren’s syndrome associated interstitial lung disease and relevant features of disease progression
Ting Zhang, Fangfang Yuan, Li Xu, et al.
Clinical Rheumatology (2020) Vol. 39, Iss. 5, pp. 1561-1568
Closed Access | Times Cited: 45
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study
Emanuele Bozzalla Cassione, Giovanni Zanframundo, Alessandro Biglia, et al.
Clinical and Experimental Rheumatology (2022) Vol. 40, Iss. 5, pp. 27-31
Open Access | Times Cited: 22
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis
M. Martel, Amélie Leurs, David Launay, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 5, pp. 103536-103536
Open Access | Times Cited: 4
Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients
AYS Lee, Karen A. Patterson, Amir Soltani, et al.
Scandinavian Journal of Rheumatology (2021) Vol. 50, Iss. 6, pp. 469-474
Closed Access | Times Cited: 25
The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren’s syndrome, cancers, and cancer metabolism
Chueh-Hsuan Hsu, Yung‐Luen Yu
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Phospho-TRIM21 orchestrates RPA2 ubiquitination switch to promote homologous recombination and tumor radio/chemo-resistance
Jie Zhang, Bin Chen, Feng Xu, et al.
Oncogene (2025)
Closed Access
Myositis autoantibodies detected by line blot immunoassay: clinical associations and correlation with antibody signal intensity
Jesús Loarce-Martos, Laura Calvo Sanz, Sandra Garrote-Corral, et al.
Rheumatology International (2023) Vol. 43, Iss. 6, pp. 1101-1109
Closed Access | Times Cited: 9
Isolated anti-Ro52 identifies a severe subset of Sjögren’s syndrome patients
Adrian Y. S. Lee, Trishni Putty, Ming‐Wei Lin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study
Léa Lopez, Thomas Barnetche, Gaël Galli, et al.
Joint Bone Spine (2023) Vol. 90, Iss. 3, pp. 105555-105555
Closed Access | Times Cited: 8
Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosis
Angela Ceribelli, Antonio Tonutti, Natasa Isailovic, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy
Jing Chen, Wen Cao, Xi Huang, et al.
Blood Advances (2023) Vol. 7, Iss. 19, pp. 5752-5770
Open Access | Times Cited: 8
Joint Hypermobility, Autonomic Dysfunction, Gastrointestinal Dysfunction, and Autoimmune Markers: Clinical Associations and Response to Intravenous Immunoglobulin Therapy
Pankaj J. Pasricha, Megan McKnight, Luisa Villatoro, et al.
The American Journal of Gastroenterology (2024) Vol. 119, Iss. 11, pp. 2298-2306
Open Access | Times Cited: 3
Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis
Danielle Tartar, Leland W.K. Chung, David Fiorentino
Clinics in Dermatology (2018) Vol. 36, Iss. 4, pp. 508-524
Closed Access | Times Cited: 26
Clinical characteristics of dermatomyositis patients with isolated anti-Ro-52 antibody associated rapid progressive interstitial lung disease: Data from the largest single Chinese center
Fang Chen, Yu Zuo, Shanshan Li, et al.
Respiratory Medicine (2019) Vol. 155, pp. 127-132
Open Access | Times Cited: 24
Recommendations from the Brazilian society of rheumatology for the diagnosis of Sjögren’s syndrome (Part I): glandular manifestations (systematic review)
Virgínia Fernandes Moça Trevisani, Sandra Gofinet Pasoto, Marilena Leal Mesquita Silvestre Fernandes, et al.
Advances in Rheumatology (2019) Vol. 59, Iss. 1
Open Access | Times Cited: 23
Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases
Paul Decker, T. Moulinet, Benjamín López, et al.
European Journal of Internal Medicine (2021) Vol. 91, pp. 45-52
Open Access | Times Cited: 20
Anti-Ro60 and anti-Ro52/TRIM21: Two distinct autoantibodies in systemic autoimmune diseases
Adrian Y. S. Lee, Joanne H. Reed, Tom P. Gordon
Journal of Autoimmunity (2021) Vol. 124, pp. 102724-102724
Closed Access | Times Cited: 20
Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer
Dimitrios P. Bogdanos, Athanasios Gkoutzourelas, Vasileios Papadopoulos, et al.
Clinica Chimica Acta (2021) Vol. 521, pp. 199-205
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top